Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins

Cisplatin is a clinically important chemotherapeutic agent known to target purine bases in nucleic acids. In addition to major deoxyribonucleic acid (DNA) intrastrand cross-links, cisplatin also forms stable adducts with many types of ribonucleic acid (RNA) including siRNA, spliceosomal RNAs, tRNA,...

Full description

Bibliographic Details
Main Authors: Gayani N. P. Dedduwa-Mudalige, Christine S. Chow
Format: Article
Language:English
Published: MDPI AG 2015-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/9/21392
_version_ 1811334738336546816
author Gayani N. P. Dedduwa-Mudalige
Christine S. Chow
author_facet Gayani N. P. Dedduwa-Mudalige
Christine S. Chow
author_sort Gayani N. P. Dedduwa-Mudalige
collection DOAJ
description Cisplatin is a clinically important chemotherapeutic agent known to target purine bases in nucleic acids. In addition to major deoxyribonucleic acid (DNA) intrastrand cross-links, cisplatin also forms stable adducts with many types of ribonucleic acid (RNA) including siRNA, spliceosomal RNAs, tRNA, and rRNA. All of these RNAs play vital roles in the cell, such as catalysis of protein synthesis by rRNA, and therefore serve as potential drug targets. This work focused on platination of two highly conserved RNA hairpins from E. coli ribosomes, namely pseudouridine-modified helix 69 from 23S rRNA and the 790 loop of helix 24 from 16S rRNA. RNase T1 probing, MALDI mass spectrometry, and dimethyl sulfate mapping revealed platination at GpG sites. Chemical probing results also showed platination-induced RNA structural changes. These findings reveal solvent and structural accessibility of sites within bacterial RNA secondary structures that are functionally significant and therefore viable targets for cisplatin as well as other classes of small molecules. Identifying target preferences at the nucleotide level, as well as determining cisplatin-induced RNA conformational changes, is important for the design of more potent drug molecules. Furthermore, the knowledge gained through studies of RNA-targeting by cisplatin is applicable to a broad range of organisms from bacteria to human.
first_indexed 2024-04-13T17:13:49Z
format Article
id doaj.art-563733c6c04f41e1a0acc35346468c82
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-13T17:13:49Z
publishDate 2015-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-563733c6c04f41e1a0acc35346468c822022-12-22T02:38:12ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-09-01169213922140910.3390/ijms160921392ijms160921392Cisplatin Targeting of Bacterial Ribosomal RNA HairpinsGayani N. P. Dedduwa-Mudalige0Christine S. Chow1Department of Chemistry, Wayne State University, Detroit, MI 48202, USADepartment of Chemistry, Wayne State University, Detroit, MI 48202, USACisplatin is a clinically important chemotherapeutic agent known to target purine bases in nucleic acids. In addition to major deoxyribonucleic acid (DNA) intrastrand cross-links, cisplatin also forms stable adducts with many types of ribonucleic acid (RNA) including siRNA, spliceosomal RNAs, tRNA, and rRNA. All of these RNAs play vital roles in the cell, such as catalysis of protein synthesis by rRNA, and therefore serve as potential drug targets. This work focused on platination of two highly conserved RNA hairpins from E. coli ribosomes, namely pseudouridine-modified helix 69 from 23S rRNA and the 790 loop of helix 24 from 16S rRNA. RNase T1 probing, MALDI mass spectrometry, and dimethyl sulfate mapping revealed platination at GpG sites. Chemical probing results also showed platination-induced RNA structural changes. These findings reveal solvent and structural accessibility of sites within bacterial RNA secondary structures that are functionally significant and therefore viable targets for cisplatin as well as other classes of small molecules. Identifying target preferences at the nucleotide level, as well as determining cisplatin-induced RNA conformational changes, is important for the design of more potent drug molecules. Furthermore, the knowledge gained through studies of RNA-targeting by cisplatin is applicable to a broad range of organisms from bacteria to human.http://www.mdpi.com/1422-0067/16/9/21392cisplatinribosomal RNAhelix 69helix 24
spellingShingle Gayani N. P. Dedduwa-Mudalige
Christine S. Chow
Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
International Journal of Molecular Sciences
cisplatin
ribosomal RNA
helix 69
helix 24
title Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
title_full Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
title_fullStr Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
title_full_unstemmed Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
title_short Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins
title_sort cisplatin targeting of bacterial ribosomal rna hairpins
topic cisplatin
ribosomal RNA
helix 69
helix 24
url http://www.mdpi.com/1422-0067/16/9/21392
work_keys_str_mv AT gayaninpdedduwamudalige cisplatintargetingofbacterialribosomalrnahairpins
AT christineschow cisplatintargetingofbacterialribosomalrnahairpins